Skip to content
REPORTWIRE NEWSROOM
About Contact
Breaking
How to book online movie tickets |ऑनलाइन मूवी टिकट बुक कैसे करें । with amazing cashback #tech Princess Anne’s Diamond Scroll Tiara FAA, Sen. Moreno say closing Burke Airport isn't an option: What it means for Cleveland After years-long revitalization process, NASCAR isn’t returning to NC racetrack Stockton Unified seeks feedback on potential Cesar Chavez High School rename Beaverton police seek public's help ID-ing bias crime assault suspect Trump downplays concerns about conditions aboard USS Abraham Lincoln Homicides Dropped 18.1% in 2025 to the Lowest Rate Since 1956, FBI Says
US News

Eli Lilly seeks FDA approval for weight loss drug tirzepatide

By 1 min read
Eli Lilly seeks FDA approval for weight loss drug tirzepatide

[ad_1]

Eli Lilly seeks FDA approval for weight loss drug tirzepatide – CBS News


Watch CBS News



Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


[ad_2]

Source link

· · · · ·

ReportWire

ReportWire newsroom contributor.

Related Stories